Safety, effectiveness, and adherence of a short and all-oral treatment regimen for the treatment of rifampicin-resistant tuberculosis in Niger: a study protocol of a pragmatic randomised clinical trial with stratified block randomisation

BACKGROUND: Rifampicin-resistant tuberculosis (RR-TB) treatment requires combination treatment, which frequently causes serious adverse events and globally results in not much more than 60% treatment success. In Niger, a high cure rate was obtained with a RR-TB treatment strategy based on a second-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Souleymane, Mahamadou Bassirou, Decroo, Tom, Soumana, Alphazazi, Maman Lawan, Ibrahim, Gagara-Issoufou, Assiatou, Halidou-Moussa, Souleymane, Ortuño-Gutiérrez, Nimer, Adehossi, Eric, Mamadou, Saïdou, Van Deun, Armand, Piubello, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746149/
https://www.ncbi.nlm.nih.gov/pubmed/36514153
http://dx.doi.org/10.1186/s13063-022-06912-7

Ejemplares similares

Ejemplares similares